journal article·2019-01

In vivo self-assembly of small diameter pulmonary visceral pleura artery graft

Xiao Lu, Ling Han, Ghassan S. Kassab

Acta Biomaterialia· Volume 83
Publisher page

Abstract

Background There is a significant clinical need for small vascular grafts <1 mm in diameter. Materials and methods The structure and composition of swine pulmonary visceral pleura (PVP) were investigated. Two processes, glutaraldehyde (GA) crosslink and decellularization (dc) plus GA crosslink, were used to inhibit the immune response. The thrombosis-resistance of the GA-crosslinked PVP (GA-PVP) was determined with in vitro and in vivo studies. Small vessel grafts with 0.7 diameter mm were constructed using the GA-PVP and surgically interposed in the femoral artery of rats for up to 24 weeks. Blood flow in the GA-PVP grafts were measured and ex vivo vascular reactivity of the prostheses were evaluated along with immuno-histological analysis. Results The GA-PVP mesothelium contains abundant glycocalyx-like substance and a smooth surface. The mechanical properties of the GA-PVP were similar to the femoral artery of rat in the range of physiological pressures. The in vitro and in vivo studies confirmed poor platelet adhesion on the GA-PVP mesothelial surface in comparison with dc processed PVP (dc-PVP). Patency of the GA-PVP prostheses in femoral arteries of rats was 86% in the 24 weeks postoperative period while patency of dc-PVP in femoral arteries of rats was 33% at 1 week postoperative period. Blood flow in the GA-PVP prostheses were not statistically different than the contralateral femoral artery. Biomarkers of neo-endothelial cells, neo-media smooth muscle cells, and extracellular matrices were observed in the GA-PVP prostheses. The significant agonists-induced vasoconstriction and endothelium-dependent vasodilation were apparent at 12 weeks and further amplified in the 24 weeks postoperative, which suggests self-assembly of functional neo-endothelium and neo-media. Conclusions The high patency and functionality of the small grafts suggest that the GA-PVP is a promising prosthetic biomaterial for vascular reconstructions. Statement of significance Small artery graft (diameter <1 mm) in the peripheral circulation that functionally arterializes has not been possible primarily due to thrombosis. Our findings indicate that lung visceral pleura may address thrombogenicity as the major pitfall in small diameter grafts. Here, grafts of 0.7 mm diameter were constructed from swine pulmonary visceral pleura (PVP) and implanted into femoral artery position of rats up to 24 weeks. The total patency of grafts in femoral arteries of rats was 86% in the 24-week period. The neo-endothelial and -medial layers were assembled in the grafts as evidenced by robust biomarkers of endothelial cells, smooth muscle cells, and extracellular matrices observed in the grafts. Agonists-induced vasoconstriction and endothelium-dependent vasodilation were apparent at 12 weeks and were amplified at 24 weeks. The high patency of the small grafts suggests that the PVP is a promising prosthetic biomaterial for vascular reconstructions.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Infectious Aortic and Vascular Conditions · Tissue Engineering and Regenerative Medicine · Electrospun Nanofibers in Biomedical Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (35)

Show source-provided references
1. The influence of biomaterials on endothelial cell thrombogenicity10.1016/j.biomaterials.2007.01.039 ↗
2. Improved endothelialization and reduced thrombosis by coating a synthetic vascular graft with fibronectin and stem cell homing factor SDF-1α10.1016/j.actbio.2011.09.016 ↗
3. Remodeling of an acellular collagen graft into a physiologically responsive neovessel10.1038/15062 ↗
4. Human tissue-engineered blood vessels for adult arterial revascularization10.1038/nm1364 ↗
5. Successful endothelialization and remodeling of a cell-free small-diameter arterial graft in a large animal model10.1016/j.biomaterials.2015.10.020 ↗
6. Click-coated, heparinized, decellularized vascular grafts10.1016/j.actbio.2014.11.015 ↗
7. Small-diameter vascular tissue engineering10.1038/nrcardio.2013.77 ↗
8. Limb salvage after vascular reconstruction followed by tissue transfer during the Global War on Terror10.1016/j.jvs.2014.10.039 ↗
9. Endothelium–role in regulation of coagulation and inflammation10.1007/s00281-011-0285-5 ↗
10. The endothelial glycocalyx: a review of the vascular barrier10.1111/anae.12661 ↗
11. Comparative decades of experience with glutaraldehyde-tanned human umbilical cord vein graft for lower limb revascularization: an analysis of 1275 cases
12. Histology and Gross Anatomy of the Respiratory Tract
13. Enhancement of the functional repertoire of the rat parietal peritoneal mesothelium in vivo: directed expression of the anticoagulant and antiinflammatory molecule thrombomodulin10.1089/hum.1998.9.7-1069 ↗
14. Glutaraldehyde as a fixative in bioprostheses and drug delivery matrices10.1016/0142-9612(96)82721-9 ↗
15. The development of prosthetic heart valves–lessons in form and function10.1056/NEJMp078175 ↗
16. Vasoactivity of blood vessels using a novel isovolumic myograph10.1007/s10439-006-9243-0 ↗
17. Assessment of endothelial function of large, medium, and small vessels: a unified myograph10.1152/ajpheart.00708.2010 ↗
18. Bovine pericardial patch angioplasty in carotid endarterectomy10.1177/000313480106700916 ↗
19. Pleural mesothelium lubrication after hyaluronidase, neuraminidase or pronase treatment10.1016/j.resp.2013.05.003 ↗
20. Elastin as a nonthrombogenic biomaterial
21. Cellular interactions with elastin10.1016/j.patbio.2004.12.022 ↗
22. Elastin as a biomaterial for tissue engineering10.1016/j.biomaterials.2007.06.025 ↗
23. Acellular vascular grafts generated from collagen and elastin analogs10.1016/j.actbio.2013.05.024 ↗
24. Biochemical and mechanical behavior of ostrich pericardium as a new biomaterial
25. Suture-reinforced electrospun polydioxanone-elastin small-diameter tubes for use in vascular tissue engineering: a feasibility study10.1016/j.actbio.2007.08.001 ↗
26. Glutaraldehyde: behavior in aqueous solution, reaction with proteins, and application to enzyme crosslinking10.2144/04375RV01 ↗
27. Glutaraldehyde-fixed bioprosthetic heart valve conduits calcify and fail from xenograft rejection10.1161/CIRCULATIONAHA.105.549311 ↗
28. Prevention of glutaraldehyde-fixed bioprosthetic heart valve calcification by alcohol pretreatment: further mechanistic studies
29. The performance of cross-linked acellular arterial scaffolds as vascular grafts; pre-clinical testing in direct and isolation loop circulatory models10.1016/j.biomaterials.2014.04.062 ↗
30. Fibroblast growth factor pretreatment of 1-MM PTFE Grafts10.1002/(SICI)1098-2752(1996)17:11<606::AID-MICR7>3.0.CO;2-M ↗
31. Small-caliber heparin-coated ePTFE grafts reduce platelet deposition and neointimal hyperplasia in a baboon model10.1016/j.jvs.2004.01.046 ↗
32. Vecchiati E, Pratesi C; Propaten Italian Registry Group. Midterm results from a multicenter registry on the treatment of infrainguinal critical limb ischemia using a heparin-bonded ePTFE graft10.1016/j.jvs.2009.12.042 ↗
33. Heparin-bonded ePTFE grafts compared with vein grafts in femoropopliteal and femorocrural bypasses: 1- and 2-year results10.1016/j.jvs.2008.12.009 ↗
34. Neo-endothelialisation of PTFE microvascular grafts: a five-year experience10.1002/micr.1920160611 ↗
35. Tissue engineering of recellularized small-diameter vascular grafts10.1089/ten.2005.11.778 ↗